Basecamp Research raises $140M Series C with Nvidia and NATO participating
AI drug discovery startup Basecamp announced a $140 million Series C; valuation and terms undisclosed, watch its AI-designed therapeutics pipeline next.
ImportanceLocalEvidenceE3 inspectableWrite-upQuick
Basecamp Research announced a $140 million Series C led by S32, with more than a dozen investors joining, including Nvidia, NATO, and the Anthology Fund, the joint venture between Anthropic and Menlo Ventures.
The company's flagship product is EDEN, a 28-billion-parameter biology foundation model trained on the Trillion Gene Atlas, a dataset covering more than 100 billion genes; its initial focus is designing in vivo cell therapies.
This is an announced round only: the announcement discloses no valuation or terms. The capital will go toward accelerating drug development and expanding partnerships with pharmaceutical companies.